Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

TNYA

Tenaya Therapeutics Inc

Dec 11 • 02:32PM ET

3.64

Dollar change +0.06
Percentage change 1.64	%

Healthcare • Biotechnology • USA • NASD

Peers: EDIT CRSP NTLA BEAM BMRN SRPT BLUE SGMO PSTX ABEO

| Held by: IWM VTI IWN VXF HRTS IWO VTWO IWC AVSC FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.48	Insider Own	17.22%	Shs Outstand	79.22M	Perf Week	6.39%
Market Cap	288.26M	Forward P/E	-	EPS next Y	-1.25	Insider Trans	-0.16%	Shs Float	65.58M	Perf Month	41.58%
Income	-117.23M	PEG	-	EPS next Q	-0.31	Inst Own	57.30%	Short Float	21.42%	Perf Quarter	76.64%
Sales	0.00M	P/S	-	EPS this Y	19.57%	Inst Trans	2.24%	Short Ratio	4.74	Perf Half Y	-4.50%
Book/sh	1.42	P/B	2.56	EPS next Y	7.86%	ROA	-70.20%	Short Interest	14.05M	Perf Year	79.25%
Cash/sh	1.00	P/C	3.63	EPS next 5Y	-	ROE	-84.49%	52W Range	1.61 - 7.01	Perf YTD	12.31%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-27.43%	ROI	-94.44%	52W High	-48.09%	Beta	2.73
Dividend TTM	-	Quick Ratio	5.27	Sales past 5Y	0.00%	Gross Margin	-	52W Low	126.01%	ATR (14)	0.35
Dividend Ex-Date	-	Current Ratio	5.27	EPS Y/Y TTM	21.78%	Oper. Margin	-	RSI (14)	67.12	Volatility	9.11% 14.22%
Employees	140	Debt/Eq	0.13	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	19.43
Option/Short	Yes / Yes	LT Debt/Eq	0.10	EPS Q/Q	24.53%	Payout	-	Rel Volume	0.84	Prev Close	3.58
Sales Surprise	-	EPS Surprise	18.37%	Sales Q/Q	-	Earnings	Nov 06 AMC	Avg Volume	2.97M	Price	3.64
SMA20	24.11%	SMA50	53.87%	SMA200	6.67%	Trades		Volume	1,956,551	Change	1.64%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-10-24	Initiated	William Blair	Outperform
Nov-30-23	Initiated	Leerink Partners	Outperform	$7
Jun-15-22	Initiated	H.C. Wainwright	Buy	$25

Nov-25-24 08:30AM	Tenaya Therapeutics Doses First Patient in RIDGE-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (GlobeNewswire) +24.37%
Nov-19-24 08:00AM	Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +10.19%
Nov-06-24 04:05PM	Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) +12.11%
Nov-03-24 06:11AM	Morgan Stanley Predicts Up to 670% Jump for These 2 Strong Buy Stocks (TipRanks)
Oct-17-24 04:30PM	Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM (GlobeNewswire) +22.86% -5.12%
08:30AM	Loading…
Sep-03-24 08:30AM	Tenaya Therapeutics to Participate in Upcoming Investment Conferences (GlobeNewswire) -5.60%
Aug-08-24 04:05PM	Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) +5.10%
Jun-27-24 05:00PM	Tenaya Therapeutics Announces Research Leadership Updates (GlobeNewswire) +8.09% +5.44%
Jun-18-24 04:30PM	Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit (GlobeNewswire)
May-16-24 12:21PM	Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating (MT Newswires)
May-15-24 07:00AM	Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170 (BioPharma Dive)
May-14-24 10:54PM	TNYA Stock Earnings: Tenaya Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
04:05PM	Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-12-24 03:26PM	13 Penny Stocks with Insider Buying in 2024 (Insider Monkey)
May-02-24 05:00PM	Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting (GlobeNewswire)
07:19AM	Loading…
Mar-26-24 07:19AM	20 Countries with the Highest Heart Disease Deaths Per Capita (Insider Monkey)
Mar-20-24 05:32AM	Tenaya Therapeutics Inc Reports Full Year and Q4 2023 Financial Results (GuruFocus.com) +8.17%
Mar-18-24 10:53PM	TNYA Stock Earnings: Tenaya Therapeutics Beats EPS for Q4 2023 (InvestorPlace) -6.02%
04:05PM	Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
08:30AM	Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine (GlobeNewswire)
Feb-29-24 03:02AM	14 Stocks With Heavy Insider Buying In 2024 (Insider Monkey)
Feb-27-24 04:30PM	Tenaya Therapeutics to Participate in Upcoming March Investor Conferences (GlobeNewswire)
Feb-26-24 09:55AM	Should You Buy Tenaya Therapeutics, Inc. (TNYA) After Golden Cross? (Zacks) +9.00%
08:30AM	Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications (GlobeNewswire)
Feb-09-24 09:55AM	Wall Street Analysts Think Tenaya Therapeutics, Inc. (TNYA) Could Surge 273.1%: Read This Before Placing a Bet (Zacks) +10.72%
Feb-08-24 08:00AM	Tenaya Therapeutics Announces Pricing of Underwritten Offering (GlobeNewswire) +16.06%
Jan-26-24 12:00PM	Tenaya Therapeutics, Inc. (TNYA) Upgraded to Strong Buy: Here's Why (Zacks)
Jan-03-24 08:30AM	Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.28%
Nov-21-23 04:30PM	Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-08-23 04:05PM	Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
08:30AM	Loading…
Oct-26-23 08:30AM	Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (GlobeNewswire) -5.67%
Oct-09-23 08:30AM	Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting (GlobeNewswire)
Oct-05-23 08:30AM	Tenaya Therapeutics Doses First Patient in the MyPeak-1 Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy (GlobeNewswire)
Oct-02-23 05:30PM	Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac Regeneration (GlobeNewswire) -5.24%
Sep-21-23 04:05PM	Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences (GlobeNewswire) +6.06%
Aug-31-23 04:05PM	Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare Conference (GlobeNewswire) -5.38%
Aug-09-23 04:05PM	Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +5.50%
Aug-02-23 04:05PM	Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference (GlobeNewswire)
May-30-23 09:06AM	With 35% stake, Tenaya Therapeutics, Inc. (NASDAQ:TNYA) seems to have captured institutional investors' interest (Simply Wall St.)
May-15-23 09:55AM	Wall Street Analysts Believe Tenaya Therapeutics, Inc. (TNYA) Could Rally 217.58%: Here's is How to Trade (Zacks)
May-11-23 08:50AM	Tenaya Therapeutics, Inc. (TNYA) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks) +7.65%
May-10-23 04:19PM	Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-03-23 08:00AM	Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting (GlobeNewswire) +12.36%
07:09AM	We Think Tenaya Therapeutics (NASDAQ:TNYA) Needs To Drive Business Growth Carefully (Simply Wall St.)
May-02-23 07:50AM	Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201 (GlobeNewswire) -11.30%
Apr-25-23 06:35AM	The 7 Best Biotech Stocks for Personalized Medicine Investors (InvestorPlace) -5.77%
Apr-23-23 04:02PM	3 Penny Stocks to Buy for 100% Returns (InvestorPlace)
Apr-21-23 04:05PM	Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit (GlobeNewswire) +22.79%
Apr-20-23 02:46PM	Why This Nasdaq Stock Caught Fire This Week (Motley Fool) +26.08%
Apr-19-23 11:36AM	These 2 Strong Buy Penny Stocks Could Rally to $40 (or More), Says Piper Sandler (TipRanks) +17.16%
Mar-08-23 04:01PM	Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire) -6.96% -12.57%
Feb-07-23 05:17PM	Tenaya Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-26-23 12:00PM	Tenaya Therapeutics, Inc. (TNYA) Upgraded to Buy: Here's What You Should Know (Zacks)
Jan-09-23 07:00AM	Tenaya Therapeutics Announces TN-201 IND Clearance and Anticipated 2023 Milestones (GlobeNewswire)
Dec-21-22 06:12AM	Insiders who placed huge bets on Tenaya Therapeutics, Inc. (NASDAQ:TNYA) earlier this year would be disappointed with the 23% drop (Simply Wall St.)
Dec-07-22 04:30PM	Tenaya Therapeutics Appoints Amy Burroughs to Board of Directors (GlobeNewswire)
Dec-02-22 06:36PM	IRobot and Acrivon Stock See Action From Activist Investors (Barrons.com)
Nov-28-22 08:30AM	Tenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy (GlobeNewswire) +7.11%
Nov-24-22 05:54AM	Here's Why Tenaya Therapeutics (NASDAQ:TNYA) Must Use Its Cash Wisely (Simply Wall St.)
Nov-23-22 09:00AM	Tenaya Therapeutics to Participate in Upcoming Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire)
Nov-21-22 05:45PM	Tenaya Therapeutics Announces Closing of Public Offering (GlobeNewswire) +9.44%
Nov-17-22 12:39AM	Tenaya Therapeutics Announces Pricing of Public Offering (GlobeNewswire) -21.63%
Nov-16-22 04:01PM	Tenaya Therapeutics Announces Proposed Public Offering (GlobeNewswire) +8.87%
Nov-10-22 04:05PM	Tenaya Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +6.81% +30.88%
Nov-04-22 08:00AM	Tenaya Therapeutics to Present Preclincial Study Data from TN-301 Program at the American Heart Association Scientific Sessions 2022 (GlobeNewswire) -17.87%
Oct-14-22 06:12AM	Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) 17% loss last week hit both individual investors who own 40% as well as institutions (Simply Wall St.)
Oct-04-22 08:30AM	Tenaya Therapeutics to Present Preclinical Data on Its Novel Engineered AAV Capsids for Cardiac Gene Delivery at the ESGCT 29th Annual Congress (GlobeNewswire)
Sep-29-22 08:00AM	Tenaya Therapeutics to Participate in Inaugural Hypertrophic Cardiomyopathy Medical Societys 2022 Scientific Sessions (GlobeNewswire) -10.42%
07:45AM	Tenaya Therapeutics to Participate in Upcoming October Investor and Industry Conferences (GlobeNewswire)
Sep-26-22 09:21AM	10 Best Biotech Stocks Under $10 (Insider Monkey)
Sep-15-22 09:39AM	Harvard Universitys Latest Portfolio: 10 Best Biotech Stock Picks (Insider Monkey)
Sep-06-22 04:05PM	Tenaya Therapeutics to Participate in Upcoming September Investor Conferences (GlobeNewswire) -7.24% +8.51%
08:00AM	Tenaya Therapeutics Announces FDA Clearance of Investigational New Drug Application and Initiation of Phase 1 Safety Study for TN-301, an HDAC6 Inhibitor for Heart Failure with Preserved Ejection Fraction (GlobeNewswire)
Aug-16-22 09:55AM	Does Tenaya Therapeutics, Inc. (TNYA) Have the Potential to Rally 368% as Wall Street Analysts Expect? (Zacks) -7.50%
Aug-10-22 04:01PM	Tenaya Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Jul-06-22 02:00PM	Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure (GlobeNewswire)
Jun-16-22 08:00AM	Tenaya Therapeutics Launches Operations of New Genetic Medicines Manufacturing Center to Support the Development of Potentially First-In-Class Cardiovascular Therapeutics (Business Wire)
May-20-22 08:30AM	Tenaya Therapeutics to Present Preclinical Data on TN-301 HDAC6 Inhibitor at European Society of Cardiology Heart Failure 2022 Conference (Business Wire) +18.33%
May-11-22 04:09PM	Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire) -12.00% +7.12%
May-07-22 09:38AM	We're Not Very Worried About Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate (Simply Wall St.)
May-03-22 08:00AM	Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting (Business Wire)
Apr-28-22 08:00AM	Tenaya Therapeutics to Present Preclinical Data on TN-401 PKP2 Gene Therapy Program at Heart Rhythm 2022 (Business Wire) +5.34%
Mar-24-22 08:30AM	Tenaya Therapeutics to Participate in Upcoming Investor Conferences (Business Wire) +12.51%
Mar-23-22 04:05PM	Tenaya Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Updates (Business Wire) -5.76%
Feb-08-22 12:01PM	Why Earnings Season Could Be Great for Tenaya Therapeutics (TNYA) (Zacks)
Feb-04-22 01:03PM	What Is The Ownership Structure Like For Tenaya Therapeutics, Inc. (NASDAQ:TNYA)? (Simply Wall St.) +7.56%
Jan-31-22 08:00AM	Tenaya Therapeutics to Participate in Upcoming Investor Conferences (Business Wire) +14.40%
Jan-10-22 08:00AM	Tenaya Therapeutics Provides 2022 Business Updates (Business Wire) -6.86%
Dec-23-21 12:38PM	Rtw Investments, Lp Buys Thermo Fisher Scientific Inc, Penumbra Inc, Tenaya Therapeutics Inc, ... (GuruFocus.com)
Dec-22-21 04:05PM	Tenaya Therapeutics Appoints Karah Parschauer, J.D., to Its Board of Directors and Joanna Auch as Senior Vice President of People and Culture (Business Wire) +8.98%
Dec-17-21 10:06AM	Harvard University Stock Portfolio: 8 Latest Stock Picks (Insider Monkey)
Nov-22-21 08:00AM	Tenaya Therapeutics Announces the Addition of Dr. June Lee to its Board of Directors (Business Wire) -8.27%
Nov-19-21 08:00AM	Tenaya Therapeutics to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference (Business Wire)
Nov-10-21 04:05PM	Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates (Business Wire) +5.87%
Nov-05-21 08:36PM	Gene Therapy Is a Huge Opportunity. It Pays to be Patient. (Barrons.com) +6.81%
03:30AM	Testing May Take Awhile, but Gene Therapy Is Poised to Tackle Mass Diseases (Barrons.com)
Nov-03-21 03:41PM	We're Not Very Worried About Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate (Simply Wall St.)
Oct-12-21 06:05PM	Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress (Business Wire) -6.02%
Oct-08-21 12:42PM	Most of this year's flood of new Bay Area public companies are 'under water' (American City Business Journals)
Oct-04-21 10:54AM	Buy These 3 New Stocks Before They Jump Over 60%, Say Analysts (TipRanks) +5.78%

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saito Chihiro	SVP, Accounting and Fin. Ops.	Nov 18 '24	Sale	2.12	2,258	4,787	60,983	Nov 18 08:48 PM
Saito Chihiro	SVP, Accounting and Fin. Ops.	Aug 16 '24	Sale	2.89	2,363	6,840	63,241	Aug 19 08:30 PM
Tingley Whittemore	Chief Medical Officer	Aug 16 '24	Sale	2.89	7,428	21,500	107,106	Aug 16 08:26 PM
Ali Faraz	Chief Executive Officer	Aug 16 '24	Sale	2.89	9,748	28,216	188,331	Aug 16 08:25 PM
Whittemore Tingley	Officer	Aug 16 '24	Proposed Sale	2.89	7,428	21,467		Aug 16 08:24 PM
Faraz Ali	Officer	Aug 16 '24	Proposed Sale	2.89	9,748	28,172		Aug 16 08:23 PM
Hoey Timothy	Chief Scientific Officer	Mar 05 '24	Sale	7.00	3,300	23,101	245,346	Mar 06 06:45 PM
Hoey Timothy	Chief Scientific Officer	Feb 20 '24	Sale	5.34	6,569	35,046	236,146	Feb 21 06:05 PM
Hoey Timothy	Chief Scientific Officer	Feb 16 '24	Sale	5.86	4,681	27,431	242,715	Feb 16 08:37 PM
Tingley Whittemore	Chief Medical Officer	Feb 16 '24	Sale	5.86	6,500	38,090	73,534	Feb 16 08:35 PM
PATTERSON LEONE D	Chief Fin. and Bus. Officer	Feb 16 '24	Sale	5.86	5,201	30,478	60,755	Feb 16 08:32 PM
Ali Faraz	Chief Executive Officer	Feb 16 '24	Sale	5.86	6,358	37,258	113,079	Feb 16 08:30 PM
COLUMN GROUP III GP, LP	10% Owner	Feb 12 '24	Buy	4.50	2,222,222	9,999,999	13,599,275	Feb 14 04:15 PM
GOEDDEL DAVID V	Director	Feb 12 '24	Buy	4.50	2,222,222	9,999,999	13,599,275	Feb 14 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TNYA

Tenaya Therapeutics Inc

Upgrade your FINVIZ experience